Linked Data API

Show Search Form

Search Results

1141108
star this property registered interest false more like this
star this property date less than 2019-07-22more like thismore than 2019-07-22
star this property answering body
Home Office more like this
star this property answering dept id 1 more like this
star this property answering dept short name Home Office more like this
unstar this property answering dept sort name Home Office more like this
star this property hansard heading Common Travel Area more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for the Home Department, what parts of the Government’s plan for travelling in the Common Travel Area in the event of a no deal Brexit have been implemented. more like this
star this property tabling member constituency Streatham more like this
star this property tabling member printed
Chuka Umunna more like this
star this property uin 280348 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-30more like thismore than 2019-07-30
unstar this property answer text <p>In the event the UK leaves the EU without a deal, there will be no practical changes to the UK’s approach to immigration on journeys within the CTA. As now there will be no routine immigration controls on journeys from within the CTA to the UK; with no immigration controls whatsoever on the Northern Ireland – Ireland land border.</p><p>Further information is set out in the UK Government publication: <a href="https://www.gov.uk/government/publications/travelling-in-the-common-travel-area-if-theres-no-brexit-deal/travelling-within-the-common-travel-area-and-the-associated-rights-of-british-and-irish-citizens-if-there-is-no-brexit-deal" target="_blank">https://www.gov.uk/government/publications/travelling-in-the-common-travel-area-if-theres-no-brexit-deal/travelling-within-the-common-travel-area-and-the-associated-rights-of-british-and-irish-citizens-if-there-is-no-brexit-deal</a></p><p> </p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
remove maximum value filtermore like thismore than 2019-07-30T16:46:44.897Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4128
unstar this property label Biography information for Chuka Umunna more like this
1138091
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Analgesics more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of using medicinal cannabis for pain relief. more like this
star this property tabling member constituency Brigg and Goole more like this
star this property tabling member printed
Andrew Percy more like this
star this property uin 275737 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>An initial impact assessment Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001 was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p> </p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication, including pain and other disorders unresponsive to existing treatments.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275738 more like this
star this property question first answered
less than 2019-07-18T09:33:54.46Zmore like thismore than 2019-07-18T09:33:54.46Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3939
unstar this property label Biography information for Andrew Percy more like this
1138094
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Irritable Bowel Syndrome: Cannabis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using medicinal cannabis to treat Irritable Bowel Syndrome. more like this
star this property tabling member constituency Brigg and Goole more like this
star this property tabling member printed
Andrew Percy more like this
star this property uin 275738 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>An initial impact assessment Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001 was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p> </p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication, including pain and other disorders unresponsive to existing treatments.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275737 more like this
star this property question first answered
less than 2019-07-18T09:33:54.507Zmore like thismore than 2019-07-18T09:33:54.507Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3939
unstar this property label Biography information for Andrew Percy more like this
1138171
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, for what reasons the Dean Street Clinic, GUM, is not permitting gay and bisexual men to take part in the PrEP impact trial. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275772 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>Pre-exposure prophylaxis (PrEP) is not currently a routinely commissioned service, but is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275773 more like this
star this property question first answered
less than 2019-07-18T09:04:29.627Zmore like thismore than 2019-07-18T09:04:29.627Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138173
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that gay and bisexual men using Dean Street Clinic (GUM) have access to PrEP as part of the PrEP Impact trial. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275773 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>Pre-exposure prophylaxis (PrEP) is not currently a routinely commissioned service, but is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275772 more like this
star this property question first answered
less than 2019-07-18T09:04:29.69Zmore like thismore than 2019-07-18T09:04:29.69Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138175
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to advertise extra places on the PrEP Impact trial to people who are at risk of HIV. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275774 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. All information regarding the Trial, including the research clinics which are open to recruitment is available at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/" target="_blank">https://www.prepimpacttrial.org.uk/</a></p><p>Following funding from NHS England to pay for extra PrEP drug and research costs and the Secretary of State’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country.</p><p>In London, boroughs have so far agreed to accept 60% of the total number of additional places available to them, which equates to over 4,000 extra places on the Trial. London local authority commissioners have been asked to confirm that they will accept the remaining 40% of additional places available to them by the end of August at the latest. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:35:43.907Zmore like thismore than 2019-07-18T09:35:43.907Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138176
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he is having with local authorities in London on increasing access to the PrEP Impact trial. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275775 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. All information regarding the Trial, including the research clinics which are open to recruitment is available at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/" target="_blank">https://www.prepimpacttrial.org.uk/</a></p><p>Following funding from NHS England to pay for extra PrEP drug and research costs and the Secretary of State’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country.</p><p>In London, boroughs have so far agreed to accept 60% of the total number of additional places available to them, which equates to over 4,000 extra places on the Trial. London local authority commissioners have been asked to confirm that they will accept the remaining 40% of additional places available to them by the end of August at the latest. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:39:40.61Zmore like thismore than 2019-07-18T09:39:40.61Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138233
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Armed Forces more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps the Government taking to expedite the availability of medicinal cannabis for soldiers suffering from PTSD. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Frank Field more like this
star this property uin 275687 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s Specialist Register to prescribe cannabis-based products for medicinal use (CBPM), where it is clinically appropriate and in the best interest of patients. Whilst the law does not restrict the conditions for which these products may be prescribed, interim guidance has been issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists. The use of medicinal cannabis to treat post-traumatic stress disorder (PTSD) is not considered, as the interim guidance focuses only on areas where the evidence base is most developed.</p><p>The National Institute for Health and Care Excellence (NICE) has been commissioned to develop updated clinical guidelines on the prescribing of CBPM, the scope of which is limited to the management of chronic pain, intractable nausea and vomiting, spasticity and severe treatment-resistant epilepsy, areas where the evidence base is most developed. The guidelines will be published by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for identifying and assessing relevant studies and delivering such guidance. NICE is expected to consult on the draft guidance between 23 July – 20 August 2019. This guidance will be routinely updated to take account of emerging evidence.</p><p>An initial impact assessment ‘Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001’ was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication and disorders unresponsive to existing treatments.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:42:32.147Zmore like thismore than 2019-07-18T09:42:32.147Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
478
unstar this property label Biography information for Frank Field more like this
1138237
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Influenza: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much funding his Department has committed to spend on campaigns to promote flu vaccination in 2019. more like this
star this property tabling member constituency Bolton West more like this
star this property tabling member printed
Chris Green more like this
star this property uin 275777 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
unstar this property answer text <p>Public Health England is planning to spend £1,300,000 on a flu vaccination campaign to encourage eligible members of the public and health and social care workers to take up the free vaccine ahead of the winter season. The spend includes expenditure for advertising on television, radio, national and regional press, outdoor, digital, and printing, excluding VAT. Figures provided are provisional and need to be reconciled following the campaign’s conclusion in November.</p><p>Flu marketing resources can be viewed at following link:</p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/34-stay-well-this-winter-/resources" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/34-stay-well-this-winter-/resources</a></p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:01:30.307Zmore like thismore than 2019-07-18T09:01:30.307Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4398
unstar this property label Biography information for Chris Green more like this
1138381
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Genito-urinary Medicine more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to his announcement, Government review confirms local authorities will continue to commission public health services, published on 7 June 2019 and paragraph 2.4 of the NHS Long Term Plan, whether he plans to publish the proposals that formed as part of his Department’s review of the commissioning arrangements for sexual and reproductive health. more like this
star this property tabling member constituency York Central more like this
star this property tabling member printed
Rachael Maskell more like this
star this property uin 276234 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-19more like thismore than 2019-07-19
unstar this property answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care announced the outcome of the review, confirming that local authorities will continue to take the lead in commissioning sexual and reproductive health, school nursing and health visiting services, at his Royal Society of Medicine lecture on 6 June.</p><p> </p><p>The review consulted a range of stakeholders. Stakeholder forums were organised by the National Aids Trust and the Public Health Systems Group, to which many organisations were invited to express their views. Officials from the Department also met with a number of organisations, and the review received a number of written submissions.</p><p> </p><p>The forthcoming Prevention Green Paper will provide an opportunity for people to give us their views on more we can do to encourage local authorities and National Health Service bodies to work well together in commissioning health services.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN
276235 more like this
276236 more like this
star this property question first answered
less than 2019-07-19T09:48:19Zmore like thismore than 2019-07-19T09:48:19Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4471
unstar this property label Biography information for Rachael Maskell more like this